Global Autacoids and Related Drugs Market: Overview
Autacoids refer to the biological factors that work like hormones and are released from body cells in response to various types of stimulations to prompt physiological responses such as treatment of a local injury or other ailments. Any imbalance in the release, synthesis, or transduction system associated with these temporarily formed biological agents trigger pathological conditions such as allergy, inflammation, and hypersensitivity. Autacoids antagonists are prescribed for the prevention of such undesirable changes to the body in response to imbalance in the operation of autacoids.
This report on the global market for autacoids and related drugs presents estimates and forecasts regarding the growth prospects of the market on global, regional, and country levels. Predictions regarding the market and its key segments are provided for the period between 2016 and 2024 based on consumption value and revenue prospects, considering 2015 as the base year. The report includes a detailed value chain analysis for all the key market segments with thorough qualitative as well as quantitative data for these segments.
The report also elucidates the key factors expected to have a sizeable impact on the overall development of the global autacoid and related drugs market over the period between 2016 and 2024. As such, key drivers, restraints, trends, regulations, and vendor and competitive landscapes are analyzed. Key growth opportunities in the autacoids and related drugs market on regional as well as global levels are also analyzed in the report. The report also includes a detailed market attractiveness analysis, wherein key applications, product varieties, and region- and country-level markets have been analyzed on the basis of attractiveness for key regional markets.
Global Autacoids and Related Drugs Market: Growth Prospects
The global market for autacoids and related drugs is expected to cross the 100 bn mark by 2018. Rising research and development activities demonstrating the use of autacoids as potential therapeutic immunomodulators for a variety of disease conditions and the increased interest in use of lipid autacoids as important therapeutic agents for treating chronic pain will be the key factors driving the market. The significant rise in cases of chronic pain across the globe and the increased focus of the medical community on the severity of chronic pain and finding effective ways to treat it are expected to make lipid autacoids a key drug candidate for the condition in the near future.
Global Autacoids and Related Drugs Market: Segmentation
Autacoids are broadly segmented into polypeptides, decarboxylated amino acids, and eicosanoids. The key varieties of polypeptides in autacoids are vasopressin, angiotensin, vasoactive intestinal polypeptide, plasma kinin, slow reacting substances of anaphylaxis, and substance P. Key varieties of decarboxylated amino acids are serotonin and histamine. The key applications of autacoids and related drugs are treatment of allergies, inflammation, gastric acid secretion, neuroendocrine regulation, chronic pain, cardiovascular diseases, gastrointestinal diseases, and anaphylactic reactions.
The key drug categories related to autacoids include drugs related to lipid-derived autacoids, polypeptide autacoids, drugs related to endothelium-derived autacoids, and biogenic amines. Of these, the segment of biogenic amines is presently the dominant drug category in the autacoids class, accounting for nearly 65% of the overall autacoids market.
In terms of geography, the market has been segmented into regions such as North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Additionally, the report also includes a country-level analysis of the market for autacoids across these regions. Data included in the report combines demand and consumption statistics for key applications and product varieties across key regions and countries.
Global Autacoids and Related Drugs Market: Companies Profiled in the Report
The report provides an exhaustive competitive outlook of the market including vast details such as the share of key companies, product portfolio, business strategies, recent developments, financial overview (wherever applicable), and strengths and weaknesses of key players operating in the global autacoids and related drugs market.
Some of the key companies operating in the global autacoid and related drugs market are Bedford Laboratories, Bristol-Myers Squibb, APP Pharma, Abbott Laboratories, Sanofi-Aventis, Chattem Inc., Xanodyne, AstraZeneca, and Hospira.
Major regions analyzed under this research report are:
- North America
- Asia Pacific
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.